Wednesday, June 10, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1226 of 1,261
  1. US 6248740

    Condensed pyridazine derivatives, their production and use

    Takeda Chemical Industries Ltd. Β· Granted Jun 19, 2001 Β· Expires Jun 14, 2021

    expired
  2. US 6248916

    Macromolecular structures for boron neutron-capture therapy

    The Regents of the University of California Β· Granted Jun 19, 2001 Β· Expires Jun 14, 2021

    expired
  3. US 6248888

    Process for the preparation of terazosin hydrochloride dihydrate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted Jun 19, 2001 Β· Expires Jun 14, 2021

    expired
  4. US 6248778

    Anticholestatic effect of luteolin

    Serturner Arzneimittel GmbH Β· Granted Jun 19, 2001 Β· Expires Jun 14, 2021

    expired
  5. US 6248528

    Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders

    The Regents of the University of California Β· Granted Jun 19, 2001 Β· Expires Jun 14, 2021

    expired
  6. US 6248788

    Therapeutic method with capsaicin and capasicin analogs

    The Regents of the University of California Β· Granted Jun 19, 2001 Β· Expires Jun 14, 2021

    expired
  7. US 6248357

    Solid pharmaceutical preparation with improved buccal disintegrability and/or dissolubility

    Takeda Chemical Industries Ltd. Β· Granted Jun 19, 2001 Β· Expires Jun 14, 2021

    expired
  8. US 6248351

    Human PEA3 is a tumor suppressor for cancer cells

    The Board of Regents of the University of Texas System Β· Granted Jun 19, 2001 Β· Expires Jun 14, 2021

    expired
  9. US 6245737

    Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  10. US 6245351

    Controlled-release composition

    Takeda Chemical Industries Ltd. Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  11. US 6245892

    Invaplex from gram negative bacteria, method of purification and methods of use

    The United States of America as represented by the Secretary of the Army Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  12. US 6245563

    Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor

    Maxim Pharmaceuticals, Inc. Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  13. US 6245560

    Vector with multiple target response elements affecting gene expression

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  14. US 6245561

    .beta.-alethine use in cell culture and therapy

    The Regents of the University of New Mexico Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  15. US 6245512

    Promoter for VEGF receptor

    The Regents of the University of California Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  16. US 6245362

    Medication for treatment of viral disease based on active agents of plant hypericum (St. John's Wort) and method of production of the medication

    Dreluso Pharmazeutika Dr. Elten & Sohn GmbH Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  17. US 6245899

    Composition for detection of cell density signal molecule

    The Regents of the University of California Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  18. US 6245743

    Inhibitors of factor Xa

    COR Therapeutics, Inc. Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  19. US 6245747

    Targeted site specific antisense oligodeoxynucleotide delivery method

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  20. US 6245752

    Compositions and methods for tolerization in immune complex-mediated disease progression

    BioCrystal, Ltd. Β· Granted Jun 12, 2001 Β· Expires Jun 7, 2021

    expired
  21. US 6241966

    Magnetic resonance imaging using Hyperpolarized noble gases

    THE TRUSTEES OF PRINCETON UNIVERSITY Β· Granted Jun 5, 2001 Β· Expires May 31, 2021

    expired
  22. US 6242473

    Treatment and prevention of reactive oxygen metabolite-mediated cellular damage

    Maxim Pharmaceuticals, Inc. Β· Granted Jun 5, 2001 Β· Expires May 31, 2021

    expired
  23. US 6241990

    Immunogenic composition containing inactivated swine infertility and respiratory Syndrome virus

    Regents of the University of Minnesota Β· Granted Jun 5, 2001 Β· Expires May 31, 2021

    expired
  24. US 6241989

    Recombinant multivalent viral vaccine

    The United States of America, as represented by the Department of Health and Human Services Β· Granted Jun 5, 2001 Β· Expires May 31, 2021

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.